149 related articles for article (PubMed ID: 18041745)
1. Bmi-1 expression predicts prognosis for patients with gastric carcinoma.
Liu JH; Song LB; Zhang X; Guo BH; Feng Y; Li XX; Liao WT; Zeng MS; Huang KH
J Surg Oncol; 2008 Mar; 97(3):267-72. PubMed ID: 18041745
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
3. [Association of Bmi-1 mRNA expression with differentiation, metastasis and prognosis of gastric carcinoma].
Huang KH; Liu JH; Li XX; Song LB; Zeng MS
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):973-5. PubMed ID: 17666329
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.
Liu WL; Guo XZ; Zhang LJ; Wang JY; Zhang G; Guan S; Chen YM; Kong QL; Xu LH; Li MZ; Song LB; Zeng MS
BMC Cancer; 2010 Sep; 10():467. PubMed ID: 20809956
[TBL] [Abstract][Full Text] [Related]
6. The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma.
Yang DD; Cui BB; Sun LY; Zheng HQ; Huang Q; Tong JX; Zhang QF
Cell Biochem Biophys; 2011 Dec; 61(3):703-10. PubMed ID: 21735131
[TBL] [Abstract][Full Text] [Related]
7. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract][Full Text] [Related]
8. [Association of Bmi-1 expression with clinicopathological features and prognosis of colorectal cancer].
Lin MX; Wen ZF; Feng ZY; Li ZK
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1816-9. PubMed ID: 19778799
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
Lin MX; Wen ZF; Feng ZY; He D
Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
[TBL] [Abstract][Full Text] [Related]
10. CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Zhang XG; Song BT; Liu FJ; Sun D; Wang KX; Qu H
Clin Transl Oncol; 2016 Jul; 18(7):700-7. PubMed ID: 26489425
[TBL] [Abstract][Full Text] [Related]
11. Expression of Bmi-1 is a prognostic marker in bladder cancer.
Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of B-cell-specific Moloney murine leukemia virus insertion site 1 expression in gastric carcinoma and its precancerous lesion.
Zhao J; Luo XD; Da CL; Xin Y
World J Gastroenterol; 2009 May; 15(17):2145-50. PubMed ID: 19418588
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.
Lu YW; Li J; Guo WJ
J Exp Clin Cancer Res; 2010 Nov; 29(1):143. PubMed ID: 21059209
[TBL] [Abstract][Full Text] [Related]
17. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
[TBL] [Abstract][Full Text] [Related]
18. Bromodomain protein 4 is a novel predictor of survival for gastric carcinoma.
Zhu Y; Yang W; Ji G; Lin N; Wu W; Xiong P; Zheng C; Yan L; Wan P; Wang Y
Oncotarget; 2017 May; 8(19):31092-31100. PubMed ID: 28415703
[TBL] [Abstract][Full Text] [Related]
19. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients.
Choi YJ; Choi YL; Cho EY; Shin YK; Sung KW; Hwang YK; Lee SJ; Kong G; Lee JE; Kim JS; Kim JH; Yang JH; Nam SJ
Breast Cancer Res Treat; 2009 Jan; 113(1):83-93. PubMed ID: 18228133
[TBL] [Abstract][Full Text] [Related]
20. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
Silva J; García V; García JM; Peña C; Domínguez G; Díaz R; Lorenzo Y; Hurtado A; Sánchez A; Bonilla F
Breast Cancer Res; 2007; 9(4):R55. PubMed ID: 17711569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
